Related Experiment Video
Updated: Jul 5, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Risk factors and microbiological characteristics of ventilator-associated pneumonia in a Tunisian intensive care unit
Hallouma Ben Fredj1, Saida Sakhri2, Abdelmajid Hafyene1
1Department of Anesthesia and Intensive Care Unit, Charles Nicolle Hospital, Tunis, Tunisia.
Background:
Ventilator-associated pneumonia (VAP) is a major intensive care unit (ICU) complication, particularly in North Africa where multidrug-resistant (MDR) organisms are frequent. This study aimed to determine risk factors, microbiological patterns, and outcomes of VAP in a Tunisian tertiary ICU during the COVID-19 pandemic.
Methods:
We conducted a retrospective observational study including 422 mechanically ventilated patients. VAP was defined using modified Johanson criteria. A multivariable logistic regression model was performed to identify independent risk factors for VAP development, in accordance with STROBE guidelines. Time-related outcomes were not included in the model to avoid temporal bias.
Results:
The VAP incidence was 24.2% (6.2 per 1000 ventilator-days), with a median onset of 8 days after intubation. Independent risk factors for VAP included polytrauma, intrahospital transport, diabetes, male sex, and age >75 years. COVID-19 ARDS was associated with a lower adjusted risk of VAP, likely reflecting selection and competing risk biases during the pandemic. Microbiological analysis showed a strong predominance of Gram-negative bacilli. Overall, 59% of isolates were MDR, mainly Acinetobacter baumannii and Klebsiella pneumoniae. Prior antibiotic exposure was strongly associated with MDR infections. ICU mortality among VAP patients was 40%, and hospital mortality reached 44%.
Conclusion:
In this pandemic-era single-center ICU cohort, VAP was associated with high morbidity and mortality and a substantial burden of MDR Gram-negative pathogens. These results highlight the impact of ICU-specific risk factors and prior antibiotic exposure, and should be interpreted within the context of a COVID-19-dominated ICU, limiting generalizability to non-pandemic settings.
Insights
Ventilator-associated pneumonia (VAP) in intensive care units (ICUs) is linked to significant risks, especially with multidrug-resistant (MDR) organisms. This study identified key risk factors and high mortality rates in a Tunisian ICU during the COVID-19 pandemic.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Epidemiology
Background:
- Ventilator-associated pneumonia (VAP) poses a significant threat in intensive care units (ICUs), particularly in regions like North Africa with a high prevalence of multidrug-resistant (MDR) organisms.
- The COVID-19 pandemic introduced unique challenges and altered patient populations within ICUs, potentially impacting VAP epidemiology.
Purpose of the Study:
- To investigate the incidence, risk factors, microbiological characteristics, and outcomes of VAP in a Tunisian tertiary ICU.
- To analyze these factors within the specific context of the COVID-19 pandemic.
Main Methods:
- A retrospective observational study involving 422 mechanically ventilated patients.
- VAP diagnosis utilized modified Johanson criteria.
- Multivariable logistic regression was employed to identify independent risk factors, adhering to STROBE guidelines.
Main Results:
- VAP incidence was 24.2% (6.2 per 1,000 ventilator-days), with a median onset of 8 days post-intubation.
- Independent risk factors included polytrauma, intrahospital transport, diabetes, male sex, and age > 75 years.
- A high proportion (59%) of Gram-negative bacilli isolates were MDR, notably *Acinetobacter baumannii* and *Klebsiella pneumoniae*. Prior antibiotic exposure correlated with MDR infections. ICU and hospital mortality rates were 40% and 44%, respectively.
Conclusions:
- VAP in this pandemic-era ICU cohort was associated with substantial morbidity, mortality, and a high burden of MDR Gram-negative pathogens.
- ICU-specific risk factors and prior antibiotic use were critical contributors.
- Findings are specific to a COVID-19-dominated ICU setting and may not be generalizable to non-pandemic periods.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
